CIK 0001937653
- Non-accelerated filer
- Smaller reporting company
Zymeworks Inc.
Sign in to watch- Ticker
- ZYME
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 883099146
- Phone
- +1 302-274-8744
- Business address
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
- Former names
- Zymeworks Delaware Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 9,560 shares at $22.67 ($216,759)
- 4 Open-market sale Chair & CEO sold 30,424 shares at $22.67 ($689,819)
- 4 Grant or award EVP, Chief Bus & Fin Officer acquired 459 shares (grant or award)
- 4 Open-market sale EVP & Chief Medical Officer sold 10,538 shares at $25.10 ($264,471)
- 4 Open-market sale Chair & CEO sold 54,343 shares at $25.10 ($1,363,841)
- 4 Open-market sale Chief Scientific Officer sold 20,110 shares at $25.10 ($504,699)
- 4 Open-market sale Chair & CEO sold 47,528 shares at $27.02 ($1,284,311)
- 4 Grant or award Director acquired 415,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director gave up 41 shares (to pay taxes)
- 4 Open-market buy Director bought 55,421 shares at an average $11.47 ($635,586)
- 4 Open-market buy Director bought 128,713 shares at an average $11.32 ($1,456,408)
- 4 Open-market buy Director bought 317,208 shares at an average $11.42 ($3,623,970)
- 4 Open-market buy Director bought 127,415 shares at an average $11.75 ($1,497,322)
- 4 Open-market buy Director bought 97,349 shares at an average $12.61 ($1,227,309)
Page 2 of 6 · 120 filings